Chris Chiu
banner
chrischiulab.bsky.social
Chris Chiu
@chrischiulab.bsky.social
Infectious diseases doctor. Immunologist. Vaccine researcher & advocate. https://profiles.imperial.ac.uk/c.chiu
Reposted by Chris Chiu
The updated US SARS-CoV-2 genomics shows a sharp increase in the NB.1.8.1 variant, and to a lesser extent XFG (combine w/ XFC).
It remains to be seen how much these, especially NB.1.8.1, can lead to a significant rise in cases here, as was seen in Asia.
More on these variants x.com/yunlong_cao/...
June 11, 2025 at 1:43 PM
Reposted by Chris Chiu
We're making viruses from public opinions! At #GERF2025 we're asking the public if they would take part in a human challenge study: green for yes, red for no, and blue for maybe. The mix of opinions is fascinating and it's clear there's a hunger to know more! 🧪@imperialinfect.bsky.social, @cepi.net
June 8, 2025 at 1:41 PM
Reposted by Chris Chiu
We had an amazing first day at the @ExRdFestival! We talked to loads of people about human challenge studies and the work of MUSICC, IMMPROVE, GERMINATE, CHANTS, Hic-Vac, and INFLAMMAGE. We're back today in South Kensington, London. Come on by! #GERF2025 @imperialinfect.bsky.social @ovg.ox.ac.uk 🧪
June 8, 2025 at 1:20 PM
Reposted by Chris Chiu
We’re almost live in DC for the #Vaccinology conference! 🎥

Catch every moment via livestream—from Dr. @peterhotezmdphd.bsky.social’s keynote to Laurence Zitvogel on how gut microbiota shapes vaccine response.

👉 Register now: keysym.us/KSVaccines25

#KSVaccines25 #KeystoneSymposia
June 4, 2025 at 4:28 PM
Very pleased to be elected to this esteemed company, with whom I hope to work closely on the most pressing health needs of our time!
Congratulations to the 54 exceptional scientists who have been elected to the Academy Fellowship today in recognition of their remarkable contributions to biomedical and health sciences 🎉

👉 Discover more: ow.ly/Cf7K50VWSRi

#HealthResearch #HealthInnovation #AcademyFellows
May 23, 2025 at 11:21 AM
Reposted by Chris Chiu
"Respiratory viruses are a major #GlobalHealth threat, and there remains an urgent need to develop the next generation of #vaccines".

@cchiu.bsky.social is helping us better understand #viruses like flu, RSV and COVID-19 — and shape the next generation of treatments.

@imperialinfect.bsky.social
May 22, 2025 at 1:28 PM
Reposted by Chris Chiu
Congratulations to our Prof Chris Chiu @cchiu.bsky.social who has been elected into the @acmedsci.bsky.social fellowship this year. 🎉

Prof Chiu is an expert in experimental medicine methods including human challenge and vaccine studies.💉

👉 imperial.ac.uk/news/264314/...
May 22, 2025 at 9:42 AM
Reposted by Chris Chiu
Huge congrats to Profs @cchiu.bsky.social, Cristina Lo Celso, Guy Rutter, Sejal Saglani, Dame Molly Stevens, & @profhelenward.bsky.social on their election as Fellows of @acmedsci.bsky.social! 👏🏻👏🏻👏🏻

www.imperial.ac.uk/news/264314/...
Six Imperial professors elected Fellows of the Academy of Medical Sciences | Imperial News | Imperial College London
Imperial scientists from fields including infectious disease, childhood asthma, and public health are among those recognised.
www.imperial.ac.uk
May 22, 2025 at 10:42 AM
Reposted by Chris Chiu
Early data from the UK RSV vaccination programme shows a 30% drop in hospital admissions for 75–79 year olds, easing NHS pressures and protecting vulnerable groups.

Read our blog to see how this vaccine's transforming public health: bit.ly/42V1NwZ

#CelebrateVaccines
April 30, 2025 at 2:28 PM
Reposted by Chris Chiu
Not all #vaccines need a needle.

Professor Chris Chiu's (@cchiu.bsky.social) latest research project—@musiccproject.bsky.social—is testing the potential of nasal and inhaled vaccines against #COVID19 and other viruses.

Read more, this #WorldImmunizationWeek 👉 www.imperial.ac.uk/Stories/the-...
April 28, 2025 at 7:33 AM
Reposted by Chris Chiu
Is an ‘exodus’ of clinical researchers threatening the future of UK healthcare?

“For young NHS clinicians coming through they are often not rewarded for what they’ve done in science whereas they used to be." – Prof Graham Cooke spoke to @financialtimes.com

www.ft.com/content/c4fa...
‘Exodus’ of clinical researchers sparks concern over future of UK healthcare
Lack of incentives is driving down the number of clinical researchers in Britain
www.ft.com
April 1, 2025 at 11:12 AM
Are you a nurse looking to join a thriving research team looking into ways to better protect against COVID-19, flu and RSV? All research training provided. Join us! www.jobs.ac.uk/job/DMJ396/c...
Clinical Research Nurse at Imperial College London
Apply for the Clinical Research Nurse role on jobs.ac.uk, the top job board for academic positions in higher education. View details and apply now.
www.jobs.ac.uk
March 25, 2025 at 11:49 AM
Reposted by Chris Chiu
From decoding deadly viruses to leading in #GlobalHealth crises—Prof Wendy Barclay’s impact is undeniable.

Now, she’s the first woman appointed Regius Professor of Infectious Disease at @imperialcollegeldn.bsky.social.

Learn more this Women at Imperial Week 👉 www.imperial.ac.uk/Stories/Wend...
Decoding viruses and defying limits: Professor Wendy Barclay appointed Regius Professor
A life dedicated to understanding viruses with pandemic potential
www.imperial.ac.uk
March 12, 2025 at 10:39 AM
Reposted by Chris Chiu
Today marks the beginning of OpenRxiv, which replaces bioRxiv and medRxiv, the world's largest preprint platform for life and medical science
openrxiv.org/introducing-...
@openrxiv.bsky.social
March 11, 2025 at 2:55 PM
Reposted by Chris Chiu
My co-EIC Florian Krammer wrote this commentary in Vaccine on the need for next generation flu vaccines to have a NA component (the N in H5N1 or H3N2).

It’s a smart idea & safeguards against bad matches to HA & other subtypes that share N1 or N2.
March 10, 2025 at 12:43 PM
Reposted by Chris Chiu
"...a balanced immune response to HA and NA would have benefits since anti-NA immunity could act as safety net in years when the HA component of the vaccine is mismatched (and vice versa)."

www.sciencedirect.com/science/arti...
Next-generation seasonal influenza virus vaccines need a neuraminidase component
www.sciencedirect.com
March 10, 2025 at 9:19 AM
Reposted by Chris Chiu
NIH is abruptly terminating at least 33 research grants for projects studying why some people are hesitant to receive vaccines or evaluating strategies that could encourage vaccine uptake. scim.ag/4how23i
NIH to ax grants on vaccine hesitancy, mRNA vaccines
Move reflects vaccine skepticism of health secretary Robert F. Kennedy Jr.
scim.ag
March 10, 2025 at 11:22 PM
Reposted by Chris Chiu
Single-cell RNA sequencing of immune cells for over 1,000 people age 18-97 years. A clock of our immune system aging. Tells us about an individual's response to infection, vaccination, Long Covid. Towards an immunome.
www.nature.com/articles/s43...
March 5, 2025 at 2:53 PM
Systematic analysis of the risks involved in controlled human infection studies with SARS-CoV-2 reassuringly highlights their acceptability and low risk in eligible participants www.sciencedirect.com/science/arti...
Assessing the risks of current COVID-19 challenge trials systematically
A large international collaboration has started a series of SARS-CoV-2 (COVID) human challenge trials (HCTs). However, critics of previously proposed …
www.sciencedirect.com
March 5, 2025 at 3:10 PM
Reposted by Chris Chiu
PubMed has been down for at least 11 hours and we are EXTREMELY concerned. We hope it’s mere incompetence and not an official action. If any of our followers have media events today, please mention it.
Opinion | Will They Come for PubMed Next?
Here's what we lose if the administration takes away this invaluable resource
www.medpagetoday.com
March 2, 2025 at 1:38 PM
Reposted by Chris Chiu
Twice a year, WHO brings together experts to analyze #influenza virus surveillance and characterization data and issue recommendations on the composition of influenza vaccines. 🧵
February 28, 2025 at 10:17 PM
Reposted by Chris Chiu
The highly pathogenic avian influenza H5N1 is an emerging and unexpected threat to many wild animal species. A Comment article in Nature Reviews Biodiversity argues that international collaboration and information-sharing is essential to enable worldwide actions. 🧪
The threat of avian influenza H5N1 looms over global biodiversity - Nature Reviews Biodiversity
The highly pathogenic avian influenza H5N1 is an emerging and unexpected threat to many wild animal species, which has implications for ecological processes, ecosystem services and conservation of threatened species. International collaboration and information-sharing is essential for surveillance, early diagnosis and the provision of financial and technical instruments to enable worldwide actions.
go.nature.com
February 22, 2025 at 2:12 AM
Reposted by Chris Chiu
A brief history of human infections with H5Ny avian influenza viruses - great to see a review not only focussed on H5N1, but also consider those H5N8 and H5N6 infections.
👉 www.cell.com/cell-host-mi...
February 20, 2025 at 6:49 AM